See Q&A With Claude Wischik. 2 October 2012. Remember Rember®—the blue dye that made headlines in 2008 when Phase 2 clinical trial data suggested it slowed decline in people with Alzheimer’s disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results